PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE
To provide compounds that induce proteolysis of Btk via a ubiquitin proteolysis pathway.SOLUTION: The present invention provides compounds of formula (I), where R1, R2, R3, R4A, R4b and R5 are as defined herein, and pharmaceutically acceptable salts thereof, which are useful as agents in treatment o...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BERENGER BIANNIC ELIZABETH L NOEY JOSHUA N PAYETTE OKANO AKINORI SHAHAB MORTEZAEI BIAN ZHIGUO JASON P BURKE ASHLEY M ADAMS VENKAT REDDY MALI ALEXEY A RIVKIN ZHAO XIANRUI MATTHEW H KATCHER VIOLETA L MARIN JIANG XINGYU JIA ZHAOZHONG J KEVIN R WOLLER SPENCER O SHOLZ JEFFERY A ZABLOCKI |
| description | To provide compounds that induce proteolysis of Btk via a ubiquitin proteolysis pathway.SOLUTION: The present invention provides compounds of formula (I), where R1, R2, R3, R4A, R4b and R5 are as defined herein, and pharmaceutically acceptable salts thereof, which are useful as agents in treatment of CLL.SELECTED DRAWING: Figure 1
【課題】ユビキチンタンパク質分解経路を介してＢｔｋのタンパク質分解を誘導する化合物を提供すること。【解決手段】本発明は、ＣＬＬの治療において薬剤として有用である、式（Ｉ）の化合物TIFF2023140319000023.tif78168［式中、Ｒ１、Ｒ２、Ｒ３、Ｒ４Ａ、Ｒ４ｂ及びＲ５は、本明細書中に定義される通りである］及び薬学的に許容されるそれらの塩を提供する。【選択図】図１ |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2023140319A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2023140319A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2023140319A3</originalsourceid><addsrcrecordid>eNrjZDAKiAzy9PV08fRzDVZw8w9ScHF1D3IEct0VnIJCQ_z91IMVQiKD_IOBChS8Pf0cg115GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8V4CRgZGxoYmBsaGlozFRigDakSdk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE</title><source>esp@cenet</source><creator>BERENGER BIANNIC ; ELIZABETH L NOEY ; JOSHUA N PAYETTE ; OKANO AKINORI ; SHAHAB MORTEZAEI ; BIAN ZHIGUO ; JASON P BURKE ; ASHLEY M ADAMS ; VENKAT REDDY MALI ; ALEXEY A RIVKIN ; ZHAO XIANRUI ; MATTHEW H KATCHER ; VIOLETA L MARIN ; JIANG XINGYU ; JIA ZHAOZHONG J ; KEVIN R WOLLER ; SPENCER O SHOLZ ; JEFFERY A ZABLOCKI</creator><creatorcontrib>BERENGER BIANNIC ; ELIZABETH L NOEY ; JOSHUA N PAYETTE ; OKANO AKINORI ; SHAHAB MORTEZAEI ; BIAN ZHIGUO ; JASON P BURKE ; ASHLEY M ADAMS ; VENKAT REDDY MALI ; ALEXEY A RIVKIN ; ZHAO XIANRUI ; MATTHEW H KATCHER ; VIOLETA L MARIN ; JIANG XINGYU ; JIA ZHAOZHONG J ; KEVIN R WOLLER ; SPENCER O SHOLZ ; JEFFERY A ZABLOCKI</creatorcontrib><description>To provide compounds that induce proteolysis of Btk via a ubiquitin proteolysis pathway.SOLUTION: The present invention provides compounds of formula (I), where R1, R2, R3, R4A, R4b and R5 are as defined herein, and pharmaceutically acceptable salts thereof, which are useful as agents in treatment of CLL.SELECTED DRAWING: Figure 1
【課題】ユビキチンタンパク質分解経路を介してＢｔｋのタンパク質分解を誘導する化合物を提供すること。【解決手段】本発明は、ＣＬＬの治療において薬剤として有用である、式（Ｉ）の化合物TIFF2023140319000023.tif78168［式中、Ｒ１、Ｒ２、Ｒ３、Ｒ４Ａ、Ｒ４ｂ及びＲ５は、本明細書中に定義される通りである］及び薬学的に許容されるそれらの塩を提供する。【選択図】図１</description><language>eng ; jpn</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231004&DB=EPODOC&CC=JP&NR=2023140319A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231004&DB=EPODOC&CC=JP&NR=2023140319A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BERENGER BIANNIC</creatorcontrib><creatorcontrib>ELIZABETH L NOEY</creatorcontrib><creatorcontrib>JOSHUA N PAYETTE</creatorcontrib><creatorcontrib>OKANO AKINORI</creatorcontrib><creatorcontrib>SHAHAB MORTEZAEI</creatorcontrib><creatorcontrib>BIAN ZHIGUO</creatorcontrib><creatorcontrib>JASON P BURKE</creatorcontrib><creatorcontrib>ASHLEY M ADAMS</creatorcontrib><creatorcontrib>VENKAT REDDY MALI</creatorcontrib><creatorcontrib>ALEXEY A RIVKIN</creatorcontrib><creatorcontrib>ZHAO XIANRUI</creatorcontrib><creatorcontrib>MATTHEW H KATCHER</creatorcontrib><creatorcontrib>VIOLETA L MARIN</creatorcontrib><creatorcontrib>JIANG XINGYU</creatorcontrib><creatorcontrib>JIA ZHAOZHONG J</creatorcontrib><creatorcontrib>KEVIN R WOLLER</creatorcontrib><creatorcontrib>SPENCER O SHOLZ</creatorcontrib><creatorcontrib>JEFFERY A ZABLOCKI</creatorcontrib><title>PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE</title><description>To provide compounds that induce proteolysis of Btk via a ubiquitin proteolysis pathway.SOLUTION: The present invention provides compounds of formula (I), where R1, R2, R3, R4A, R4b and R5 are as defined herein, and pharmaceutically acceptable salts thereof, which are useful as agents in treatment of CLL.SELECTED DRAWING: Figure 1
【課題】ユビキチンタンパク質分解経路を介してＢｔｋのタンパク質分解を誘導する化合物を提供すること。【解決手段】本発明は、ＣＬＬの治療において薬剤として有用である、式（Ｉ）の化合物TIFF2023140319000023.tif78168［式中、Ｒ１、Ｒ２、Ｒ３、Ｒ４Ａ、Ｒ４ｂ及びＲ５は、本明細書中に定義される通りである］及び薬学的に許容されるそれらの塩を提供する。【選択図】図１</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAKiAzy9PV08fRzDVZw8w9ScHF1D3IEct0VnIJCQ_z91IMVQiKD_IOBChS8Pf0cg115GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8V4CRgZGxoYmBsaGlozFRigDakSdk</recordid><startdate>20231004</startdate><enddate>20231004</enddate><creator>BERENGER BIANNIC</creator><creator>ELIZABETH L NOEY</creator><creator>JOSHUA N PAYETTE</creator><creator>OKANO AKINORI</creator><creator>SHAHAB MORTEZAEI</creator><creator>BIAN ZHIGUO</creator><creator>JASON P BURKE</creator><creator>ASHLEY M ADAMS</creator><creator>VENKAT REDDY MALI</creator><creator>ALEXEY A RIVKIN</creator><creator>ZHAO XIANRUI</creator><creator>MATTHEW H KATCHER</creator><creator>VIOLETA L MARIN</creator><creator>JIANG XINGYU</creator><creator>JIA ZHAOZHONG J</creator><creator>KEVIN R WOLLER</creator><creator>SPENCER O SHOLZ</creator><creator>JEFFERY A ZABLOCKI</creator><scope>EVB</scope></search><sort><creationdate>20231004</creationdate><title>PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE</title><author>BERENGER BIANNIC ; ELIZABETH L NOEY ; JOSHUA N PAYETTE ; OKANO AKINORI ; SHAHAB MORTEZAEI ; BIAN ZHIGUO ; JASON P BURKE ; ASHLEY M ADAMS ; VENKAT REDDY MALI ; ALEXEY A RIVKIN ; ZHAO XIANRUI ; MATTHEW H KATCHER ; VIOLETA L MARIN ; JIANG XINGYU ; JIA ZHAOZHONG J ; KEVIN R WOLLER ; SPENCER O SHOLZ ; JEFFERY A ZABLOCKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2023140319A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BERENGER BIANNIC</creatorcontrib><creatorcontrib>ELIZABETH L NOEY</creatorcontrib><creatorcontrib>JOSHUA N PAYETTE</creatorcontrib><creatorcontrib>OKANO AKINORI</creatorcontrib><creatorcontrib>SHAHAB MORTEZAEI</creatorcontrib><creatorcontrib>BIAN ZHIGUO</creatorcontrib><creatorcontrib>JASON P BURKE</creatorcontrib><creatorcontrib>ASHLEY M ADAMS</creatorcontrib><creatorcontrib>VENKAT REDDY MALI</creatorcontrib><creatorcontrib>ALEXEY A RIVKIN</creatorcontrib><creatorcontrib>ZHAO XIANRUI</creatorcontrib><creatorcontrib>MATTHEW H KATCHER</creatorcontrib><creatorcontrib>VIOLETA L MARIN</creatorcontrib><creatorcontrib>JIANG XINGYU</creatorcontrib><creatorcontrib>JIA ZHAOZHONG J</creatorcontrib><creatorcontrib>KEVIN R WOLLER</creatorcontrib><creatorcontrib>SPENCER O SHOLZ</creatorcontrib><creatorcontrib>JEFFERY A ZABLOCKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BERENGER BIANNIC</au><au>ELIZABETH L NOEY</au><au>JOSHUA N PAYETTE</au><au>OKANO AKINORI</au><au>SHAHAB MORTEZAEI</au><au>BIAN ZHIGUO</au><au>JASON P BURKE</au><au>ASHLEY M ADAMS</au><au>VENKAT REDDY MALI</au><au>ALEXEY A RIVKIN</au><au>ZHAO XIANRUI</au><au>MATTHEW H KATCHER</au><au>VIOLETA L MARIN</au><au>JIANG XINGYU</au><au>JIA ZHAOZHONG J</au><au>KEVIN R WOLLER</au><au>SPENCER O SHOLZ</au><au>JEFFERY A ZABLOCKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE</title><date>2023-10-04</date><risdate>2023</risdate><abstract>To provide compounds that induce proteolysis of Btk via a ubiquitin proteolysis pathway.SOLUTION: The present invention provides compounds of formula (I), where R1, R2, R3, R4A, R4b and R5 are as defined herein, and pharmaceutically acceptable salts thereof, which are useful as agents in treatment of CLL.SELECTED DRAWING: Figure 1
【課題】ユビキチンタンパク質分解経路を介してＢｔｋのタンパク質分解を誘導する化合物を提供すること。【解決手段】本発明は、ＣＬＬの治療において薬剤として有用である、式（Ｉ）の化合物TIFF2023140319000023.tif78168［式中、Ｒ１、Ｒ２、Ｒ３、Ｒ４Ａ、Ｒ４ｂ及びＲ５は、本明細書中に定義される通りである］及び薬学的に許容されるそれらの塩を提供する。【選択図】図１</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2023140319A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T15%3A40%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BERENGER%20BIANNIC&rft.date=2023-10-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2023140319A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |